A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis

MLA

Richard Hafner, et al. “A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis.” New England Journal of Medicine, vol. 337, July 1997, pp. 315–20. EBSCOhost, https://doi.org/10.1056/nejm199707313370505.

APA

Richard Hafner, Marina B. Klein, C L Besch, George Perez, S Szabo, John P. Matts, Wafaa El-Sadr, Carol Miller, A Vaughn, Lawrence S. Brown, F M Gordin, & S L John. (1997). A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis. New England Journal of Medicine, 337, 315–320. https://doi.org/10.1056/nejm199707313370505

Chicago

Richard Hafner, Marina B. Klein, C L Besch, George Perez, S Szabo, John P. Matts, Wafaa El-Sadr, et al. 1997. “A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis.” New England Journal of Medicine 337 (July): 315–20. doi:10.1056/nejm199707313370505.